iAtoday
Group Benefits
and Retirement Solutions
To develop and implement our drug management strategies, our experts constantly monitor and analyze a number of key indicators. One of these indicators is the ranking of the ten drugs responsible for the highest expenses for all group insurance plans.
Reviewing these top ten drugs allows us to consider the best course of action and develop the most effective drug management strategies for our clients.
Haven’t yet read our pharmacist’s analysis? See her full review in our thought leadership space Insights.
Read the article
“Ongoing surveillance of high-cost therapies, biosimilar adoption and evolving treatment pathways helps us identify savings opportunities and support sustainable drug plan management.”
Erika Hatherly, Pharmacist and Strategic Leader, Drug Programs
Group Benefits and Retirement Solutions
Need help getting a better grasp on the industry?
Our Insights thought leadership space offers content that combines our know-how with a visionary perspective. It can help you better understand key industry trends and developments, get you thinking and even inspire you.
Our thought leadership content—articles and white papers—is yet another way we help you get ahead by offering clients innovative solutions that meet their constantly evolving needs in total wellbeing.
Also in this issue
- Defined benefit plans | Simplifying risk management
- A new campaign to promote healthy digital habits
- Access to My Client Space | Upcoming changes for plan members
- 2025 Sustainability Report | Succeeding now and tomorrow
- Grand défi Pierre Lavoie | Cycling to support youth again this year
- Alternative funds | Stability over higher returns
- Semi-Annual Investment Fund Evaluation | Winter 2026 edition available
- Asset management│Fund managers announce changes and a new appointment
- Empowering women at work: why health, financial wellbeing and equity go hand in hand
- May 4-10: Let’s support mental health